Long-term outcome of patients with lupus erythematodes and Antiphospholipid Syndrome after cardiac valve surgery

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
R. Arif ◽  
P. Seppelt ◽  
M. Zaradzki ◽  
M. Farag ◽  
A. Ruhparwar ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Valve Surgery ◽  
Lupus Erythematodes ◽  
Cardiac Valve ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Cardiac Valve Surgery

scholarly journals 062 * PATIENTS WITH LUPUS ERYTHEMATODES AND ANTIPHOSPHOLIPID SYNDROME UNDERGOING CARDIAC VALVE SURGERY

2014 ◽  
Vol 19 (suppl 1) ◽  
pp. S19-S19
Author(s):  
R. Arif ◽  
P. Seppelt ◽  
M. Farag ◽  
M. Zaradzki ◽  
A. Ruhparwar ◽  
...  
Keyword(s):  
Antiphospholipid Syndrome ◽  
Valve Surgery ◽  
Lupus Erythematodes ◽  
Cardiac Valve ◽  
Cardiac Valve Surgery

Predictors of the Long-Term Outcome After Combined Aortic and Mitral Valve Surgery

Circulation ◽  
1999 ◽  
Vol 100 (Supplement 2) ◽  
pp. II-48-II-53 ◽  
Author(s):  
J. Turina ◽  
T. Stark ◽  
B. Seifert ◽  
M. Turina
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-Term Outcome of Patients with Antiphospholipid Syndrome Who Undergo Percutaneous Coronary Intervention

Cardiology ◽  
2012 ◽  
Vol 122 (2) ◽  
pp. 76-82 ◽  
Author(s):  
Leor Perl ◽  
Adi Netzer ◽  
Eldad Rechavia ◽  
Tamir Bental ◽  
Abid Assali ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Antiphospholipid Syndrome ◽  
Coronary Intervention ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Percutaneous Coronary

scholarly journals Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation

2018 ◽  
Vol 155 (3) ◽  
pp. 983-994 ◽  
Author(s):  
Niv Ad ◽  
Sari D. Holmes ◽  
Paul S. Massimiano ◽  
Anthony J. Rongione ◽  
Lisa M. Fornaresio
Keyword(s):  
Atrial Fibrillation ◽  
Mitral Valve ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Maze Procedure ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome after atrioventricular valve surgery following modified Fontan operation

2010 ◽  
Vol 21 (1) ◽  
pp. 83-88 ◽  
Author(s):  
Shaji C. Menon ◽  
Joseph A. Dearani ◽  
Frank Cetta
Keyword(s):  
Ventricular Function ◽  
Fontan Procedure ◽  
Fontan Operation ◽  
Valve Surgery ◽  
Atrioventricular Valve ◽  
Term Outcome ◽  
Protein Losing Enteropathy ◽  
Long Term Outcome

AbstractObjectiveThe objective of this study was to evaluate the early and late results of atrioventricular valve surgery after Fontan operation.BackgroundAtrioventricular valve regurgitation is a known perioperative risk factor for Fontan operation. There are limited data on the outcomes of late atrioventricular valve surgery following Fontan operation.MethodsPatients who underwent atrioventricular valve surgery following Fontan procedure were identified from the Mayo Clinic Fontan database. Medical records were reviewed for pre-operative, operative, and post-operative clinical and haemodynamic data. All patients not known to be deceased were sent health status questionnaires.ResultsA total of 61 patients (28 females) underwent atrioventricular valve surgery following Fontan procedure. The median age at atrioventricular valve surgery was 14 years. The median duration between Fontan and atrioventricular valve surgery was 4.7 years. Median follow-up was 9 years. There were a total of 32 (52%) deaths with 8 (13%) within 30 days of surgery. The 5-, 10-, and 15-year survival rates were 67%, 57%, and 45%, respectively. On follow-up, 44 of 61 (72%) had arrhythmias, 21 of 29 (72%) were symptomatic, and 12 of 61 (20%) developed protein-losing enteropathy. On multivariate analysis, reduced ventricular function and development of protein-losing enteropathy were associated with decreased survival.ConclusionAtrioventricular valve surgery after Fontan procedure is associated with substantial late morbidity and mortality. Atrioventricular valve surgery in this cohort of patients portends poor long-term outcome and is associated with a high incidence of protein-losing enteropathy. Reduced ventricular function and development of protein-losing enteropathy were associated with decreased survival.

Sign in / Sign up

Export Citation Format

Share Document